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j Abstract Objectives Community based data were
used to examine the association between social phobia
and comorbidity, quality of life and service utilization.
In addition, the correlations of the number of social
fears with these domains were studied. Method Data
are from the Netherlands Mental Health Survey and
Incidence Study (NEMESIS) (N = 7,076). Social pho-
bia was assessed according to DSM-III-R with the
Composite International Diagnostic Interview (CIDI);
quality of life was assessed according to the Short-
Form-36 Health Survey (SF-36). Results The 12-
month prevalence of social phobia was 4.8%. Being
female, young, low educated, a single parent, living
alone, not having a paid job and having a somatic
disorder are associated with 12-month social phobia.
Mean and median ages of onset of social phobia were
19.1 and 16.0 years, respectively, and mean and
median duration were 16.8 and 14.0 years, respec-
tively. 66% of respondents with social phobia had at
least one comorbid condition. 12-month social phobia
was significantly related to lower quality of life and
higher service utilization. The mean number of feared
social situations was 2.73 out of the 6 assessed. As the
number of social fears increases, comorbidity and
service utilization increases, and the quality of life
decreases. Conclusions These findings suggest as the
number of feared social situations increases, the bur-
den of social phobia rises. In other words, like
comorbidity or decreased quality of life, the number of
social fears is also an important indicator of the
severity of social phobia. We conclude that from a
public health perspective, mental health care givers
should pay attention to the number of social fears in
order to check the severity of social phobia.
j Key words social phobia – number of social fears
– help-seeking behaviour – quality of life – comor-
bidity
Introduction
Social phobia is a highly prevalent disorder [8, 10, 11,
13, 16, 17, 20, 24], which is associated with huge loss
in quality of life, [34, 39] enormous economic costs,
[25] high levels of service use, [23, 28, 33], serious
functional impairments in the areas of education,
social and occupational domains [8, 19, 28], and high
comorbidity rates with other anxiety and mood dis-
orders [7, 18].
It is not yet clear whether specific subtypes of so-
cial phobia can be distinguished. In clinical samples,
several types of social phobias have been found, with
one group of patients suffering exclusively from per-
formance fears (such as speaking in public), while
others suffer from a broader range of fears, including
both performance fears and interactional fears (such
as meeting new people). [19, 35] Generalized social
phobia has been defined as a social phobia in which
both performance fears and interactional fears occur
together. [27] However, it has also been defined as a
social phobia in which multiple social fears occur
together.
Although there is some evidence that different
types of social phobia do indeed exist, it has also been
suggested that there is stronger evidence that social
phobia should be seen as a unidimensional condition,
[22, 27, 34] in which an increasing number of feared
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situations is related to increased functional impair-
ments and psychological problems [4, 12, 32, 34]. This
would suggest that social phobia exists on a contin-
uum of severity.
Whether social phobia exists on a continuum of
increasing severity with the numbers of fears, how-
ever, has not been studied conclusively yet. Some
studies have examined whether evidence could be
found for such a continuum by examining the rela-
tionship between severity and functional impairment
[4, 27, 34]. However, most of these studies used
clinical samples, and have not examined other rele-
vant indicators of severity, such as service utilization,
overall quality of life, and comorbidity.
We examined these issues in the data of the
Netherlands Mental Health Survey and Incidence
Study (NEMESIS), a large, representative, population-
based study in which the presence of social phobia
and other mental disorders was determined by well-
validated diagnostic interviews. More specifically, we
examined whether we can find support for the
hypothesis that social phobia exists on a continuum
of increasing severity with the numbers of fears
ranging from one social fear to multiple social fears,
and whether this number of social fears is related to
quality of life, comorbidity with other DSM-III-R Axis
I disorders and service utilization.
Methods
j Sample
NEMESIS was based on a multistage, stratified, random sampling
procedure [5]. Initially, a sample was drawn of 90 Dutch
municipalities stratified on the basis of urbanization and ade-
quate dispersion over the 12 provinces in the Netherlands. Sec-
ondly, a sample of private households (addresses) from post
office registers was gathered. The number of households selected
in each municipality was determined by the size of its popula-
tion. The third step was to choose which individuals to inter-
view. The residents of the selected households were sent a letter
of introduction signed by the Minister of Public Health
requesting them to take part. Afterwards, the interviewers con-
tacted the residents by telephone. Households with no telephone
or with ex-directory numbers (18%) were visited in person. One
respondent with the most recent birthday was randomly selected
in each household, on condition that s(he) was between 18 and
64 years of age and sufficiently fluent in Dutch to be interviewed.
Persons who were not immediately available because of cir-
cumstances such as hospitalization, travel or imprisonment were
contacted later in the year. If necessary, to make a contact, the
interviewers made a minimum of ten calls or visits at a given
address at different times of the day and week. In the first round
of the data collection, from February through December 1996, a
total of 7,076 persons were interviewed (response rate of 69.7%).
Refusal was the most important reason for non-response. The
sample reflected adequately the Dutch population in terms of
gender, civil status and urbanization level [5]. The data was
collected by 90 experienced interviewers. All of the interviewers
went through a 3-day training course in recruiting respondents
and computer assisted interviewing. After that, a 4-day course of
training focused specifically on the content of NEMESIS and the
use of CIDI at the WHO-CIDI training center of the Academic
Medical Center in Amsterdam was given.
j Measures
Diagnoses of mental disorders
The diagnoses were based on DSM-III-R Axis I [2, 26]. The Composite
International Diagnostic Interview (CIDI) version 1.1 (computerised
version) was used to determine the diagnoses [41]. The CIDI is a
structured interview developed by the World Health Organization [30,
40] on the basis of Diagnostic Interview Schedule (DIS) and the Present
State Examination (PSE). It was designed for use by trained inter-
viewers who are not clinicians. The CIDI is now being used worldwide,
and WHO field trials have documented acceptable reliability and
validity for nearly all diagnoses [26, 31, 40] with the exception of acute
psychotic presentations. Whenever psychotic symptoms were de-
tected, subjects were reinterviewed by trained interviewers with the
Structured Clinical Interview for DSM-III-R, an instrument that is
reliable and valid for diagnosing schizophrenia [31].
The CIDI was used to determine the lifetime, 12-month, and
one-month prevalence of mood, anxiety, substance-related and
eating disorders. In the current study, we used the 12-month data
of social phobia, as well as the 12-month data of comorbid anxiety
disorders (panic disorder, agoraphobia, simple phobia, obsessive
compulsive disorder, generalized anxiety disorder), mood disor-
ders (depression, dysthymia, bipolar disorder), and substance use
disorders (alcohol, drug, or any substance abuse or dependence).
Because of the low prevalence of eating disorders and psychotic
disorders, these disorders were not examined in this study. For
comorbidity patterns, the hierarchical rules of DSM-III-R were ig-
nored. Applying the hierarchical rules would have resulted in social
phobia subjects being missed if they also had another DSM-III-R
disorder which has the hierarchical precedence [3].
Number of social fears
Consistent with the DSM-III-R, respondents were asked if they had
excessive or unreasonable fear in six social situations (speaking in
public, talking to people when you might have nothing to say or
might sound foolish, talking in front of a small group, using public
toilets, eating or drinking in public places and writing while being
observed), and tried to avoid it or felt intensely anxious, in the past
12 months. For each subject with a 12-month social phobia, we
calculated the total number of social fears he or she had.
Quality of life
Was assessed with the 36 item Short Form-36 Health Survey (SF-36,
a = 0.88) [36, 37]. A higher score indicates better functioning. The
SF-36 has eight subscales. The ‘physical functioning’ scale (10 items)
measures the health related limitations regarding daily activities such
as bathing, getting dressed and going up and down stairs. The ‘role
limitations due to physical problems’ (four items) and ‘role limita-
tions due to emotional problems’ (three items) scales assess problems
occurring in the previous 4 weeks that arose from physical health
symptoms or emotional difficulties. The ‘vitality’ scale (four items)
measures lack of energy and fatigue. ‘Social functioning’ scale (two
items) records limitations regarding social activities such as visiting
friends and relatives. The ‘pain’ scale (two items) pertains to the
amount of bodily pain and its limiting effect. The ‘general health
perception’ scale (five items) measures the individual’s own assess-
ment of his or her general health. The last scale ‘mental health’ (five
items) measures the feelings of depression or nervousness.
Service utilization
Questions were asked about help from primary care (general
practitioner, company physician, crisis care, general social worker,
home care/district nursing), informal care (alternative care pro-
vider, self-help group, traditional healer, telephone help line,
physiotherapist/haptonomist) and from mental health care (com-
munity mental health care institute, psychiatric outpatient clinic
of a psychiatric or general hospital, independent psychiatrist or
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psychotherapist) within the past 12 months, in order to assess
whether the respondents had sought help for their psychological or
drug/alcohol related problems.
Demographic variables
Gender, age, level of education (low, medium, high), and cohabi-
tation status (living alone or not).
j Analyses
We examined the relationship between the number of social fears
and comorbidity with logistic regression analyses in which the
presence (yes/no) of the comorbid disorder was used as dependent
variable, and the number of social fears was entered as predictor
while controlling for demographic variables.
In order to examine the effect of the presence of social phobia
and the number of social fears on the domains of quality of life, we
conducted two separate series of linear regression analyses in which
the domains of quality of life were used as the dependent variable.
In the first analyses, the presence of social phobia was entered after
controlling for sociodemographic variables. Then, in the second
analyses, the number of social fears was entered as a continuous
predictor, while controlling for demographic variables.
The relationship with help-seeking was examined with a logistic
regression analysis in which help-seeking (yes/no) was used as
dependent variable, and the number of social fears was entered as
predictor.
The data were weighted in all analyses to adjust for different
response rates in different population groups for the characteristics
that are associated with the occurrence of psychiatric disorders
such as gender, age, marital status (two categories: married, not
married) and urbanization (seven categories). The weighting
procedures have been described in more detail elsewhere [5].
Furthermore, because earlier research has shown that several
demographic variables are associated with social phobia, we ad-
justed for demographics in all analyses [8, 11, 16].
Results
j Prevalence of social phobia and number of social
fears
The 12-month prevalence of social phobia was 4.8%,
while the mean age of onset was 19.3 years (SD =
11.7). The mean duration of lifetime social phobia was
19.2 years (SD = 13.5). The 12-month prevalence of
social phobia was significantly associated with being
female, of a younger age, being less well educated, and
living alone (Table 1).
Among the respondents with 12-month social
phobia, the mean number of feared social situations
was 2.73 (SD = 1.35) out of six situations. Twenty-one
point zero percent of social phobics feared only one
social situation, while 25.9% feared two situations,
26.8% feared three situations, and 25.9% feared four
to six social situations.
For respondents with social phobia, public speak-
ing was the most common fear (82.0%). The second
most common fear was also a speaking fear, ‘‘fear of
speaking when you might have nothing to say or
might sound foolish’’ (61.1%). Third was talking in
front of a small group (55.0%), followed by writing
while being observed (29.7%), eating and drinking in
public (21.6%), and using public toilets (18.0 %).
j Association between social phobia and number
of social fears, and comorbidity
As can be seen in Table 2, subjects with social phobia
have a significantly increased chance of having one or
more of the studied comorbid mental disorders, with
the exception of alcohol and drug abuse. About two-
thirds (66.2%) of the respondents with social phobia
reported at least one other mental health disorder.
Social phobia is especially strongly associated with
obsessive compulsive disorder (OR: 14.26, 95% CI:
6.95–29.26), bipolar disorder (OR: 13.09, 95% CI:
8.49–19.99), agoraphobia without panic disorder (OR:
12.76, 95% CI: 8.51–19.14), and panic disorder (OR:
12.74, 95% CI: 8.95–18.13).
Table 2 shows that the level of comorbidity with
mood and anxiety disorders increases significantly
with the number of social fears. About 38% of the
socially phobic subjects with one social fear have a
comorbid anxiety disorder, and this percentage in-
creases steadily with an increasing number of social
fears. About 92% of the subjects with five or six fears
have a comorbid anxiety disorder. About 27% of the
socially phobic subjects with one social fear have a
comorbid mood disorder, while 56% of the subjects
with five or six fears have a mood disorder. For the
separate anxiety and mood disorders significant linear
trends were found, with the exception of generalized
anxiety disorders, and bipolar disorders. We also
found few indications that the number of social fears
was associated with comorbid substance-related dis-
orders. For illustrative purposes, we have graphically
presented the association between number of social
Table 1 Association (odds ratios)
between demographic variables and
12-month social phobia
Demographics Social
phobia (%)
No Social
phobia (%)
OR
(unadj)
95%
CI
OR*
(adj)
95%
CI
Female gender 63.2 48.7 1.81 1.45–2.28 1.74 1.39–2.19
Level of education
Low 12.1 6.0 1 (ref) 1 (ref)
Medium 47.8 35.9 0.66 0.46–0.94 0.60 0.42–0.87
High 40.0 58.1 0.34 0.24–0.49 0.28 0.19–0.42
Living alone 25.1 17.3 1.60 1.24–2.06 1.81 1.40–2.35
Age: M (SD) 40.2 (11.6) 41.2 (12.2) 0.99 0.99–1.00 0.99 0.98–0.99
*Odds ratios have been controlled for gender, age, level of education, and cohabitation status
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fears and comorbid mood, anxiety and substance-
related disorders in Fig. 1.
j Association between social phobia and number
of social fears, and health-related quality of life
When we compared subjects with a social phobia to
those without, we found that social phobics had sig-
nificantly lower scores in all eight dimensions of
functioning (Table 3).
As expected, an increasing number of social fears
was associated with a decreased level of health-related
quality of life. However, from Table 3, it can be seen
that social phobics with only one social fear have no
dramatically different scores than the subjects without
social phobia.
j Association between social phobia and number
of social fears and service utilization
The association between social phobia and help-
seeking is presented in Table 4. As could have been
expected, subjects with a social phobia have sought
treatment more often than subjects without social
phobia, and this is true for help from primary care,
mental health care, and informal care.
A higher number of social fears was significantly
associated with more help-seeking behaviour. A total
of 52% of subjects with one social fear sought help,
while 93% of the subjects with five or six social fears
sought help. For illustrative purposes, we have
graphically presented the number of social fears and
the percentage of subjects who sought help (Fig. 2).
Discussion
j Epidemiological results
The 12-month prevalence rate (4.8%) in the present
study was rather lower than the previous findings
(6.7–7.9%) conducted in Norway, Canada and United
States of America which used DSM-III-R criteria and
the CIDI [11, 17, 21, 24]. This may be clarified by two
explanations. First, there might be cultural differences
Table 2 Proportion of subjects with 12-month social phobia with comorbid mental disorders, according to number of social fears
SPPresent or not Number of fears
SP No SP ORa 95% CI 1 2 3 4 5/6 OR a 95% CI
Any disorder % % % % % % %
>1 DSM III-R disorder 66.2 19.7 6.91*** 5.40–8.85 58 61.9 75.9 92 96.6 1.88*** 1.49–2.37
Anxiety disorders
Panic disorder 17.8 1.4 12.74*** 8.95–18.13 4.5 12.6 22.7 17.2 43.3 1.75*** 1.39–2.20
Agoraphobia 12.4 1.0 12.76*** 8.51–19.14 4.2 9.6 10.3 11.0 40.0 1.84*** 1.41–2.40
Simple phobia 37 5.6 8.63*** 6.72–11.09 23.5 29.8 41.8 54.4 49.0 1.37*** 1.14–1.65
GAD 16.7 1.8 8.94*** 6.34–12.62 10.0 22.8 8.0 24.8 27.6 NS
OCD 4.3 0.3 14.26*** 6.95–29.26 0.7 1.2 4.0 10.8 11.7 2.43*** 1.48–4.00
Any anxiety disorder 61.8 15.7 8.39*** 6.62–10.62 38.1 55.4 68.4 77.7 92.4 1.87*** 1.51–2.31
Mood disorders
Major depression 29.3 4.7 7.32*** 5.62–9.55 18.5 27.2 30.1 31.4 49.9 1.37*** 1.14–1.64
Dysthymia 20.3 2.2 9.11*** 6.62–12.53 7.0 14.7 26.0 20.1 44.9 1.65*** 1.33–2.05
Bipolar disorder 11 0.9 13.09*** 8.49–19.99 5.0 10.1 16.7 9.8 12.9 NS
Any Mood disorder 40.6 6.4 8.76*** 6.87–10.92 26.6 37.9 45.9 45.2 56.4 1.35*** 1.13–1.61
Substance related disorders
Alcohol abuse 4.6 4.6 NS 6.5 2 5.8 6.4 1.7 NS
Alcohol dependence 7.5 3.5 2.67*** 1.72–4.17 10.0 1.2 10.6 6.6 10.1 NS
Drug abuse 0.6 0.5 NS – – – 2.4 2.5 4.12 0.73–23.32
Drug dependence 5 0.6 7.63 4.23–13.76 4.3 3.3 5.4 10.1 3.9 NS
Any substance related disorder 15.2 8.6 2.43*** 1.75–3.37 16.5 6.5 18.4 23.1 16.5 NS
aOdds ratios have been controlled for sex, age, level of education, and cohabitation
*P £ 0.05
**P £ 0.01
***P £ 0.001
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in psychiatric disorders also between the western
countries. Second, the diagnostic instruments might
be translated and administered in a somewhat dif-
ferent method in each country [25]. In addition, other
explanations could be the differences in sampling and
research methods used. Our result for mean age of
onset (19.3 years) is consistent with earlier commu-
nity based studies (14.6–24.3 years) [8, 13, 22, 23, 38].
Similar to the previous results [4, 8, 9], social phobia
lasts a long time with a mean duration of 19.2 years in
our sample.
The demographic results of the present study are
mainly consistent with the majority of the previous
studies. Respondents who are female, younger, less
well educated and not working are more likely to have
social phobia [6, 8, 11, 13, 15, 22, 23]. Furthermore,
social phobia was found to occur more in single
parents and those who live alone [9, 28].
Our findings showed that social phobics were using
primary care, informal care and mental health care to
a greater extent compared to people without social
phobia. Consistent with the previous research [8], we
also found that they were using those care services not
for phobic anxiety but for other complaints. It is
possible that they fear scrutiny even in health care
locations and prefer to present with physical com-
plaints or other problems that are different from so-
cial phobia. Thus, we can suggest to health care
professionals to check for underlying social phobia in
those cases where they may have suspicions.
j The number of social fears
We found clear indications that the number of social
fears in subjects with social phobia is related to levels
Table 3 Quality of life, as measured with the MOS-SF-36, in subjects with 12-month social phobia, according to number of social fears
SP present or not Number of fears
SP No SP Betaa R2
Changea, b
1 2 3 4 5/6 Betaa R2
Changea, b
Physical func. Mean (SD) 86.1 (20.5) 92.3 (15.3) )0.050** 0.002 92.3 (12.8) 83.6 (22.5) 88.1 (18.1) 82.7 (26.3) 78.7 (23.4) )0.113* 0.011
Physical role func. Mean (SD) 73.1 (38.3) 86.4 (29.2) )0.058** 0.003 86.2 (27.4) 73.0 (39.6) 76.5 (34.2) 54.7 (45.4) 59.8 (44.6) )0.193** 0.033
Psych. role func. Mean (SD) 71.1 (40.6) 93.1 (21.6) )0.152** 0.022 82.8 (33.7) 72.9 (38.8) 76.0 (36.7) 61.1 (45.2) 44.2 (47.4) )0.205** 0.037
Vitality Mean (SD) 55.6 (21.8) 72.2 (17.7) )0.133** 0.017 63.4 (18.1) 54.9 (23.7) 57.8 (18.9) 51.6 (19.2) 41.7 (26.0) )0.179** 0.029
Psych. health Mean (SD) 63.9 (21.1) 82.7 (14.0) )0.189** 0.034 72.3 (15.7) 65.4 (21.4) 64.5 (19.2) 61.1 (21.5) 46.4 (23.3) )0.237** 0.05
Social functioning Mean (SD) 75.6 (25.2) 90.3 (17.1) )0.123** 0.014 87.1 (17.1) 76.8 (26.0) 75.8 (25.4) 67.2 (24.6) 59.7 (27.2) )0.267** 0.063
Pain Mean (SD) 75.3 (26.1) 85.8 (21.2) )0.059** 0.003 86.2 (18.2) 75.4 (26.2) 75.4 (24.8) 66.5 (32.8) 63.6 (26.9) )0.205** 0.037
General health Mean (SD) 61.5 (21.1) 75.0 (17.4) )0.113** 0.012 67.2 (18.1) 61.4 (20.1) 63.5 (19.3) 57.6 (23.9) 50.8 (25.3) )0.147** 0.019
aR2 Change and beta-coefficients have been controlled for sex, age, level of education, cohabitation and comorbidity with any other DSM III-R disorder
bR2 Change indicates how much of the overall variance is explained by the presence of social phobia or the number of social fears after the effects of
sociodemographics and other DSM-III-R disorders are removed
*P £ 0.05
**P £ 0.01
Table 4 Service use in subjects with 12-month social phobia, according to number of social fears
SP present or
not
Number of fears
SP No SP OR 1a 95% CI OR 2b 95% CI 1 2 3 4 5/6 OR 1a 95% CI OR 2b 95% CI
% % % % % % %
Primary care 65.4 27 4.81* (3.81–6.08) 2.70* (2.11–3.46) 45.4 64.6 64.6 80.8 91.0 1.68* (1.37–2.05) 1.49* (1.18–1.88)
Informal care 33.8 9.8 4.21* (3.30–5.37) 2.44* (1.88–3.16) 21.4 33.1 30.2 37.7 63 1.44* (1.20–1.72) 1.47* (1.18–1.82)
Mental health care 49 16.6 4.88* (3.88–6.14) 2.54* (1.96–3.29) 27.9 46.5 44 70.6 83.7 1.77* (1.46–2.14) 1.28* (1.06–1.55)
Any help 71 31.2 5.06* (3.96–6.46) 2.81* (2.15–3.67) 52.0 68.4 73.7 84.7 92.8 1.72* (1.39–2.14) 1.62* (1.33–1.97)
aOdds ratios have been controlled for gender, age, level of education, and cohabitation
bOdds ratios have been controlled for gender, age, level of education, cohabitation and comorbidity with any other DSM-III-R disorder
*P £ 0.01
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of comorbidity, to domains of health-related quality
of life, and to help-seeking behaviour. The larger the
number of social fears, the higher the chance of
having a comorbid anxiety or mood disorder, poorer
quality of life and an increased likelihood of help-
seeking. This indicates that the number of social fears
is clearly associated with indicators of disability.
Earlier research already demonstrated that the
number of fears is associated with a decreased level of
quality of life [14, 27, 34] and increased chance of
comorbidity [35], but this study is the first general
population-based study that shows the number of fears
is also related to higher levels of help-seeking in terms
of primary, informal and mental health care services.
The ‘category versus dimension’ issue has been
examined in many mental health disorders such as
mood and personality disorders. Although this debate
still continues, there is some evidence indicating that
depression [14], bipolar disorder II [1], and person-
ality disorders [29] may possibly be better understood
as existing on a continuum, rather than as discrete
categorical disorders. Moreover, in the definition of
‘generalized social phobia’, DSM-IV-R requires fears
of most social situations which emphasizes the con-
tinuum of the disorder. Although, the present findings
indicate that as the number of social fears increases,
the burden of social phobia also increases, it is not
enough to conclude that social phobia lies on a con-
tinuum with the present data. In order to claim that,
the data needs to include also the subjects under the
diagnostic threshold of social phobia.
The present findings show that there might be
thresholds in number of social fears in terms of
severity of the disorder. For example, in service uti-
lization there could be a threshold between having
three or four social fears. From the results it seems
that while social phobics with three fears try to
manage their problems by primary or informal care,
those with four or more fears take mental health care.
Whether there is a clear threshold between number of
fears could be examined in future studies. Moreover,
it seems as if having only one social fear has not much
negative influence on quality of life, while with
increasing number of social fears quality of life dra-
matically decreases. However, the explained variance
by the number of fears is relatively low. Thus, future
studies are needed to examine the impact of the fac-
tors of social phobia also other than the number of
social fears on quality of life.
From a public health perspective, we can suggest
that mental health care givers should pay attention to
the number of social fears in order to check the
severity of social phobia. The information may be
helpful to prepare the most appropriate treatment
plans according to the severity of the social phobia.
For instance, with comprehensive interventions that
target the different domains of life, social phobics
could learn to manage better with the difficulties at
work, school or in other areas.
The present study should be considered in the
light of several limitations. First, the results have
been gathered from just one wave, so it is not pos-
sible to make causal relationships between the
severity of the social phobia in terms of comorbidity,
help-seeking behaviour, quality of life and the
number of social fears. Second, our study assessed
only six social fears. A broader range of social sit-
uations would make the current results more confi-
dent. Finally, comorbidity is limited to DSM-III-R
Axis I disorders. Personality disorders, which might
give a broader view about the respondents with so-
cial phobia, were not included.
Despite these limitations, however, this study has
made it clear that the number of social fears is an
important variable in determining the severity of
social phobia. These results indicate that as the
number of social fears increases social phobia be-
comes more severe and the burden of the disorder,
in terms of comorbidity and quality of life, turn out
to be heavier.
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